Distribution of small intestinal mucosal injuries as a result of NSAID administration

Eur J Clin Invest 2010; 40 (6): 504–510 Background  Nonsteroidal anti‐inflammatory drugs (NSAIDs) induce small intestinal mucosal injuries. The concentrations of NSAIDs, bile acids and intestinal flora may differ in the proximal and distal parts of the small intestine. This study aimed to analyse ty...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of clinical investigation Vol. 40; no. 6; pp. 504 - 510
Main Authors Fujimori, Shunji, Gudis, Katya, Takahashi, Yoko, Seo, Tsuguhiko, Yamada, Yukie, Ehara, Akihito, Kobayashi, Tsuyoshi, Mitsui, Keigo, Yonezawa, Masaoki, Tanaka, Shu, Tatsuguchi, Atsushi, Sakamoto, Choitsu
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.06.2010
Wiley-Blackwell
Subjects
Online AccessGet full text
ISSN0014-2972
1365-2362
1365-2362
DOI10.1111/j.1365-2362.2010.02290.x

Cover

Loading…
Abstract Eur J Clin Invest 2010; 40 (6): 504–510 Background  Nonsteroidal anti‐inflammatory drugs (NSAIDs) induce small intestinal mucosal injuries. The concentrations of NSAIDs, bile acids and intestinal flora may differ in the proximal and distal parts of the small intestine. This study aimed to analyse types and distributions of NSAID‐induced small intestinal injuries. Subjects and methods  In total 55 healthy male volunteers were examined using baseline capsule endoscopy (CE). Subjects then undertook a 14‐day regimen of NSAID medication (diclofenac sodium, 75 mg day−1) with proton‐pump inhibitors (omeprazole 20 mg day−1) as gastroprotection. After 14 days, subjects underwent post‐treatment CE and were assessed for three types of small intestinal injuries: denuded areas, erosions and ulcers. The proximal and distal parts of the small intestine were arbitrarily classified according to CE transit time from the duodenal bulb. Results  Baseline CE revealed six mucosal lesions in 6 of 55 subjects (11%), consisting of three denuded areas and three erosions. Post‐treatment CE identified 636 lesions in 32 of 53 subjects (60%); including 115 denuded areas in 16 subjects, 498 erosions in 22 subjects and 23 ulcers in 8 subjects. The distribution of small intestinal injuries differed according to type; denuded areas (90%: 103/115) were predominantly located in the proximal part, erosions throughout the small intestine and all ulcers in the distal part. The location of ulcers and denuded areas differed statistically (P < 0·0001). Conclusions  The impact of short‐term NSAID medication on the small intestine differed according to intestinal site, with most denuded areas identified in the proximal part and all ulcers in the distal part.
AbstractList Nonsteroidal anti-inflammatory drugs (NSAIDs) induce small intestinal mucosal injuries. The concentrations of NSAIDs, bile acids and intestinal flora may differ in the proximal and distal parts of the small intestine. This study aimed to analyse types and distributions of NSAID-induced small intestinal injuries.BACKGROUNDNonsteroidal anti-inflammatory drugs (NSAIDs) induce small intestinal mucosal injuries. The concentrations of NSAIDs, bile acids and intestinal flora may differ in the proximal and distal parts of the small intestine. This study aimed to analyse types and distributions of NSAID-induced small intestinal injuries.In total 55 healthy male volunteers were examined using baseline capsule endoscopy (CE). Subjects then undertook a 14-day regimen of NSAID medication (diclofenac sodium, 75 mg day(-1)) with proton-pump inhibitors (omeprazole 20 mg day(-1)) as gastroprotection. After 14 days, subjects underwent post-treatment CE and were assessed for three types of small intestinal injuries: denuded areas, erosions and ulcers. The proximal and distal parts of the small intestine were arbitrarily classified according to CE transit time from the duodenal bulb.SUBJECTS AND METHODSIn total 55 healthy male volunteers were examined using baseline capsule endoscopy (CE). Subjects then undertook a 14-day regimen of NSAID medication (diclofenac sodium, 75 mg day(-1)) with proton-pump inhibitors (omeprazole 20 mg day(-1)) as gastroprotection. After 14 days, subjects underwent post-treatment CE and were assessed for three types of small intestinal injuries: denuded areas, erosions and ulcers. The proximal and distal parts of the small intestine were arbitrarily classified according to CE transit time from the duodenal bulb.Baseline CE revealed six mucosal lesions in 6 of 55 subjects (11%), consisting of three denuded areas and three erosions. Post-treatment CE identified 636 lesions in 32 of 53 subjects (60%); including 115 denuded areas in 16 subjects, 498 erosions in 22 subjects and 23 ulcers in 8 subjects. The distribution of small intestinal injuries differed according to type; denuded areas (90%: 103/115) were predominantly located in the proximal part, erosions throughout the small intestine and all ulcers in the distal part. The location of ulcers and denuded areas differed statistically (P < 0.0001).RESULTSBaseline CE revealed six mucosal lesions in 6 of 55 subjects (11%), consisting of three denuded areas and three erosions. Post-treatment CE identified 636 lesions in 32 of 53 subjects (60%); including 115 denuded areas in 16 subjects, 498 erosions in 22 subjects and 23 ulcers in 8 subjects. The distribution of small intestinal injuries differed according to type; denuded areas (90%: 103/115) were predominantly located in the proximal part, erosions throughout the small intestine and all ulcers in the distal part. The location of ulcers and denuded areas differed statistically (P < 0.0001).The impact of short-term NSAID medication on the small intestine differed according to intestinal site, with most denuded areas identified in the proximal part and all ulcers in the distal part.CONCLUSIONSThe impact of short-term NSAID medication on the small intestine differed according to intestinal site, with most denuded areas identified in the proximal part and all ulcers in the distal part.
Eur J Clin Invest 2010; 40 (6): 504–510 Background  Nonsteroidal anti‐inflammatory drugs (NSAIDs) induce small intestinal mucosal injuries. The concentrations of NSAIDs, bile acids and intestinal flora may differ in the proximal and distal parts of the small intestine. This study aimed to analyse types and distributions of NSAID‐induced small intestinal injuries. Subjects and methods  In total 55 healthy male volunteers were examined using baseline capsule endoscopy (CE). Subjects then undertook a 14‐day regimen of NSAID medication (diclofenac sodium, 75 mg day−1) with proton‐pump inhibitors (omeprazole 20 mg day−1) as gastroprotection. After 14 days, subjects underwent post‐treatment CE and were assessed for three types of small intestinal injuries: denuded areas, erosions and ulcers. The proximal and distal parts of the small intestine were arbitrarily classified according to CE transit time from the duodenal bulb. Results  Baseline CE revealed six mucosal lesions in 6 of 55 subjects (11%), consisting of three denuded areas and three erosions. Post‐treatment CE identified 636 lesions in 32 of 53 subjects (60%); including 115 denuded areas in 16 subjects, 498 erosions in 22 subjects and 23 ulcers in 8 subjects. The distribution of small intestinal injuries differed according to type; denuded areas (90%: 103/115) were predominantly located in the proximal part, erosions throughout the small intestine and all ulcers in the distal part. The location of ulcers and denuded areas differed statistically (P < 0·0001). Conclusions  The impact of short‐term NSAID medication on the small intestine differed according to intestinal site, with most denuded areas identified in the proximal part and all ulcers in the distal part.
Nonsteroidal anti-inflammatory drugs (NSAIDs) induce small intestinal mucosal injuries. The concentrations of NSAIDs, bile acids and intestinal flora may differ in the proximal and distal parts of the small intestine. This study aimed to analyse types and distributions of NSAID-induced small intestinal injuries. In total 55 healthy male volunteers were examined using baseline capsule endoscopy (CE). Subjects then undertook a 14-day regimen of NSAID medication (diclofenac sodium, 75 mg day(-1)) with proton-pump inhibitors (omeprazole 20 mg day(-1)) as gastroprotection. After 14 days, subjects underwent post-treatment CE and were assessed for three types of small intestinal injuries: denuded areas, erosions and ulcers. The proximal and distal parts of the small intestine were arbitrarily classified according to CE transit time from the duodenal bulb. Baseline CE revealed six mucosal lesions in 6 of 55 subjects (11%), consisting of three denuded areas and three erosions. Post-treatment CE identified 636 lesions in 32 of 53 subjects (60%); including 115 denuded areas in 16 subjects, 498 erosions in 22 subjects and 23 ulcers in 8 subjects. The distribution of small intestinal injuries differed according to type; denuded areas (90%: 103/115) were predominantly located in the proximal part, erosions throughout the small intestine and all ulcers in the distal part. The location of ulcers and denuded areas differed statistically (P < 0.0001). The impact of short-term NSAID medication on the small intestine differed according to intestinal site, with most denuded areas identified in the proximal part and all ulcers in the distal part.
Author Mitsui, Keigo
Tanaka, Shu
Sakamoto, Choitsu
Ehara, Akihito
Yonezawa, Masaoki
Tatsuguchi, Atsushi
Fujimori, Shunji
Takahashi, Yoko
Yamada, Yukie
Gudis, Katya
Seo, Tsuguhiko
Kobayashi, Tsuyoshi
Author_xml – sequence: 1
  givenname: Shunji
  surname: Fujimori
  fullname: Fujimori, Shunji
  organization: Nippon Medical School, Tokyo, Japan
– sequence: 2
  givenname: Katya
  surname: Gudis
  fullname: Gudis, Katya
  organization: Nippon Medical School, Tokyo, Japan
– sequence: 3
  givenname: Yoko
  surname: Takahashi
  fullname: Takahashi, Yoko
  organization: Nippon Medical School, Tokyo, Japan
– sequence: 4
  givenname: Tsuguhiko
  surname: Seo
  fullname: Seo, Tsuguhiko
  organization: Nippon Medical School, Tokyo, Japan
– sequence: 5
  givenname: Yukie
  surname: Yamada
  fullname: Yamada, Yukie
  organization: Nippon Medical School, Tokyo, Japan
– sequence: 6
  givenname: Akihito
  surname: Ehara
  fullname: Ehara, Akihito
  organization: Nippon Medical School, Tokyo, Japan
– sequence: 7
  givenname: Tsuyoshi
  surname: Kobayashi
  fullname: Kobayashi, Tsuyoshi
  organization: Nippon Medical School, Tokyo, Japan
– sequence: 8
  givenname: Keigo
  surname: Mitsui
  fullname: Mitsui, Keigo
  organization: Nippon Medical School, Tokyo, Japan
– sequence: 9
  givenname: Masaoki
  surname: Yonezawa
  fullname: Yonezawa, Masaoki
  organization: Nippon Medical School, Tokyo, Japan
– sequence: 10
  givenname: Shu
  surname: Tanaka
  fullname: Tanaka, Shu
  organization: Nippon Medical School, Tokyo, Japan
– sequence: 11
  givenname: Atsushi
  surname: Tatsuguchi
  fullname: Tatsuguchi, Atsushi
  organization: Nippon Medical School, Tokyo, Japan
– sequence: 12
  givenname: Choitsu
  surname: Sakamoto
  fullname: Sakamoto, Choitsu
  organization: Nippon Medical School, Tokyo, Japan
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22788413$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20412292$$D View this record in MEDLINE/PubMed
BookMark eNqNkUFv1DAQhS1URLeFv4ByQZyyjO04cQ4glW3ZrlTKAQrcrEliS16cpNiJ2P577O62SJxqWbI1ft-zx--EHA3joAnJKCxpHO-2S8pLkTNesiWDWAXGaljunpHF48ERWQDQImd1xY7JSQhbAJCUsxfkmEFBI8EW5ObchsnbZp7sOGSjyUKPzmV2mHSY7IAu6-d2DJhK29lbHTKMM_M6zG5KwPXXs815hl1vh2SFyegleW7QBf3qsJ6Sm08X31aX-dWX9WZ1dpW3QjDIGywAmrrTXJamK9qCFmUN0miNRUcZhU7WqBlUuhECDS9NXTZSdFhqMCgYPyVv9763fvw9xxer3oZWO4eDHuegKs45BSaT8vVBOTe97tSttz36O_XwE1Hw5iDA0KIzHofWhn86VklZUB51H_a61o8heG1Ua6f7pmPv1ikKKkWktioloVISKkWk7iNSu2gg_zN4uOMJ6Ps9-sc6ffdkTl2sNmkX-XzPx6D07pFH_0uVFa-E-nG9Vpefxfr7Gj6qn_wv9rC2uA
CitedBy_id crossref_primary_10_1038_clpt_2012_79
crossref_primary_10_1097_MOG_0000000000000522
crossref_primary_10_2169_naika_100_50
crossref_primary_10_1186_1471_230X_12_121
crossref_primary_10_3748_wjg_v20_i31_11012
crossref_primary_10_1002_jat_3391
crossref_primary_10_1007_s11356_021_12652_z
crossref_primary_10_3390_ph3041187
crossref_primary_10_3904_kjim_2021_216
crossref_primary_10_1007_s00394_016_1304_z
crossref_primary_10_3164_jcbn_17_46
crossref_primary_10_3164_jcbn_18_16
crossref_primary_10_1177_0960327118819044
crossref_primary_10_2169_internalmedicine_53_1572
crossref_primary_10_3390_diagnostics11112123
crossref_primary_10_1007_s00535_011_0501_z
crossref_primary_10_1016_j_pathol_2020_05_009
crossref_primary_10_1111_den_15002
crossref_primary_10_1007_s00535_010_0332_3
crossref_primary_10_1016_j_vascn_2015_11_008
crossref_primary_10_1007_s12328_013_0424_8
crossref_primary_10_5946_ce_2012_45_2_138
crossref_primary_10_4166_kjg_2016_68_2_123
crossref_primary_10_5009_gnl240247
crossref_primary_10_17116_terarkh20158712134_137
crossref_primary_10_7759_cureus_37080
crossref_primary_10_1097_MCG_0b013e3182618506
crossref_primary_10_1186_s41021_021_00205_2
crossref_primary_10_1016_j_ijpharm_2012_05_063
crossref_primary_10_1016_j_nut_2019_110583
crossref_primary_10_1155_2013_761060
crossref_primary_10_1097_MOG_0000000000000427
crossref_primary_10_1111_eci_12001
crossref_primary_10_1002_med_21331
crossref_primary_10_1111_j_1476_5381_2011_01509_x
crossref_primary_10_1016_j_ejmech_2019_06_034
crossref_primary_10_1111_den_12883
crossref_primary_10_1517_14740338_2014_924924
crossref_primary_10_1080_00365521_2019_1575466
crossref_primary_10_3810_pgm_2011_07_2316
crossref_primary_10_1016_j_jff_2014_12_048
crossref_primary_10_3390_jcm12165272
crossref_primary_10_1007_s00535_011_0410_1
crossref_primary_10_3748_wjg_v23_i22_3954
crossref_primary_10_1016_j_rgmxen_2019_11_001
crossref_primary_10_14789_jmj_60_94
crossref_primary_10_1111_jgh_12980
crossref_primary_10_1002_pds_1857
crossref_primary_10_1093_toxsci_kfs310
crossref_primary_10_1007_s12328_013_0364_3
crossref_primary_10_3164_jcbn_16_49
crossref_primary_10_1007_s00296_013_2756_6
crossref_primary_10_1007_s00535_014_1028_x
crossref_primary_10_1186_s12876_018_0923_7
crossref_primary_10_1016_j_dld_2012_05_016
crossref_primary_10_36106_ijsr_1921250
crossref_primary_10_1186_s12916_015_0285_8
crossref_primary_10_1371_journal_pone_0035196
crossref_primary_10_1016_j_trsl_2016_03_014
crossref_primary_10_1016_j_rgmx_2019_11_003
crossref_primary_10_21886_2712_8156_2020_1_1_64_69
crossref_primary_10_1053_j_gastro_2011_06_075
crossref_primary_10_1111_apt_16642
crossref_primary_10_4078_jrd_2017_24_1_27
crossref_primary_10_1016_j_cgh_2015_10_022
crossref_primary_10_1016_j_phrs_2015_12_031
crossref_primary_10_4166_kjg_2016_67_6_300
crossref_primary_10_1007_s00535_019_01657_8
crossref_primary_10_1186_1471_230X_13_108
Cites_doi 10.1016/0016-5085(93)90667-2
10.1172/JCI107720
10.1016/S1542-3565(04)00603-2
10.1016/S0014-2999(01)01327-9
10.3164/jcbn.SR09-58
10.1056/NEJM199209103271101
10.1016/0016-5085(87)90909-7
10.1053/j.gastro.2005.03.020
10.1136/gut.33.9.1204
10.1080/00365520701794121
10.1016/S0016-5085(70)80149-4
10.1016/S1542-3565(04)00619-6
10.2152/jmi.51.43
10.1136/gut.33.7.887
10.1055/s-2007-967014
10.1136/gut.42.3.366
10.1016/S0140-6736(84)92739-9
10.1016/0140-6736(91)91300-J
10.1007/BF01316493
10.1016/0005-2760(76)90278-2
10.1016/S0016-5085(97)70225-7
10.1111/j.1365-2036.2007.03312.x
10.1016/j.ejphar.2004.07.042
10.1016/j.gie.2008.08.017
ContentType Journal Article
Copyright 2010 The Authors. Journal Compilation © 2010 Stichting European Society for Clinical Investigation Journal Foundation
2015 INIST-CNRS
Copyright_xml – notice: 2010 The Authors. Journal Compilation © 2010 Stichting European Society for Clinical Investigation Journal Foundation
– notice: 2015 INIST-CNRS
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/j.1365-2362.2010.02290.x
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2362
EndPage 510
ExternalDocumentID 20412292
22788413
10_1111_j_1365_2362_2010_02290_x
ECI2290
ark_67375_WNG_HM5GVG0B_X
Genre article
Journal Article
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
29G
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EAD
EAP
EAS
EBB
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK0
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZGI
ZXP
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACUHS
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c5520-ba400b9de386fd4c4146908feea4d1210d89ae207eb55af36f96b85da6e0fa523
IEDL.DBID DR2
ISSN 0014-2972
1365-2362
IngestDate Tue Aug 05 10:29:37 EDT 2025
Mon Jul 21 06:02:46 EDT 2025
Mon Jul 21 09:12:51 EDT 2025
Tue Jul 01 00:53:22 EDT 2025
Thu Apr 24 22:57:05 EDT 2025
Wed Jan 22 17:06:58 EST 2025
Wed Oct 30 09:53:11 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Digestive system
Mucosa
NSAID
denuded area
Small intestine
Trauma
Result
Non steroidal antiinflammatory agent
Medicine
Capsule endoscopy
Distribution
small intestinal injury
Lesion
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5520-ba400b9de386fd4c4146908feea4d1210d89ae207eb55af36f96b85da6e0fa523
Notes istex:67B77217605741F043D8115AC7DB273EAA154F0D
ark:/67375/WNG-HM5GVG0B-X
ArticleID:ECI2290
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2362.2010.02290.x
PMID 20412292
PQID 733310282
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_733310282
pubmed_primary_20412292
pascalfrancis_primary_22788413
crossref_citationtrail_10_1111_j_1365_2362_2010_02290_x
crossref_primary_10_1111_j_1365_2362_2010_02290_x
wiley_primary_10_1111_j_1365_2362_2010_02290_x_ECI2290
istex_primary_ark_67375_WNG_HM5GVG0B_X
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2010
PublicationDateYYYYMMDD 2010-06-01
PublicationDate_xml – month: 06
  year: 2010
  text: June 2010
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
PublicationTitle European journal of clinical investigation
PublicationTitleAlternate Eur J Clin Invest
PublicationYear 2010
Publisher Blackwell Publishing Ltd
Wiley-Blackwell
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley-Blackwell
References Fujimori S, Seo T, Gudis K, Ehara A, Kobayashi T, Mitsui K et al. Prevention of NSAID-induced small intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointest Endosc 2009;69:1339-46.
Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005;3:55-9.
Higuchi K, Yoda Y, Amagase K, Kato S, Tokioka S, Murano M et al. Prevention of NSAID-induced small intestinal mucosal injury: prophylactic potential of lansoprazole. J Clin Biochem Nutr 2009;45:125-30.
Spittell D, Vongroven LK, Subbiah MT. Concentration changes of bile acids in sequential segments of pigeon intestine and their relation to bile acid absorption. Biochim Biophys Acta 1976;441:32-7.
Reuter BK, Davies NM, Wallace JL. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria and enteropathic circulation. Gastroenterology 1997;112:109-17.
Bjarnason I, Hayllar J, Smethurst P, Price A, Gumpel MJ. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut 1992;33:1204-8.
Morris AJ, Madhok R, Sturrock RD, Capell HA, MacKenzie JF. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet 1991;337:520.
Koga H, Aoyagi K, Matsumoto T, Iida M, Fujishima M. Experimental enteropathy in athymic and euthymic rats: synergistic role of lipopolysaccharide and indomethacin. Am J Physiol 1999;276(3 Pt 1):G576-82.
Matsumoto T, Kudo T, Esaki M, Yano T, Yamamoto H, Sakamoto C et al. Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gastroenterol 2008;43:490-6.
Davies GR, Wilkie ME, Rampton DS. Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability. Dig Dis Sci 1992;38:417-25.
Bjarnason I, Williams P, So A, Zanelli GD, Levi AJ, Gumpel JM et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 1984;2:1171-4.
Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005;3:133-41.
Evans SM, Whittle BJ. Interactive roles of superoxide and inducible nitric oxide synthase in rat intestinal injury provoked by non-steroidal anti-inflammatory drugs. Eur J Pharmacol 2001;429:287-96.
Krag E, Phillips SF. Active and passive bile acid absorption in man. Perfusion studies of the ileum and jejunum. J Clin Invest 1974;53:1686-94.
Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule endoscopy. Gastroenterology 2005;128:1172-8.
Whittle BJ. Mechanisms underlying intestinal injury induced by anti-inflammatory COX inhibitors. Eur J Pharmacol 2004;500:427-39.
Fujimori S, Seo T, Gudis K, Tanaka S, Mitsui K, Kobayashi T et al. Diagnosis and treatment of obscure gastrointestinal bleeding using combined capsule endoscopy and double balloon endoscopy: 1-year follow-up study. Endoscopy 2007;39:1053-8.
Fujimori S, Seo T, Takahashi Y, Gudis K, Yamada Y, Tatsuguchi A et al. Prevention of NSAID-induced small intestinal injury by rebamipide: a prospective, double-blind, randomized controlled trial. Gastroenterology 2009;136(Suppl. 1):A880.
Bjarnason I, Hayllar J, MacPherson AJ, Russel AS. Side effects of non-steroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993;104:1832-47.
Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Aisenberg J, Bhadra P et al. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther 2007;15:1211-22.
Hagiwara M, Kataoka K, Arimochi H, Kuwahara T, Ohnishi Y. Role of unbalanced growth of gram-negative bacteria in ileal ulcer formation in rats treated with a nonsteroidal anti-inflammatory drug. J Med Invest 2004;51:43-51.
Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P et al. Non-steroidal anti-inflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987;93:480-9.
Allison MC, Howatson AG, Torrance CJ, Lee FD, Russel RI. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med 1992;327:749-54.
Wax J, Clinger WA, Varner P, Bass P, Winder CV. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. Gastroenterology 1970;58:772-80.
Morris AJ, MacKenzie JF. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 1992;33:887-9.
Hao WL, Lee YK. Microflora of the gastrointestinal tract: a review. Methods Mol Biol 2004;268:491-502.
Kelly DA, Piasecki C, Anthony A, Dhillon AP, Pounder RE, Wakefield AJ. Focal reduction of villous blood flow in early indomethacin enteropathy: a dynamic vascular study in the rat. Gut 1998;42:366-73.
2007; 39
2009; 45
2009; 69
1976; 441
2004; 500
2004; 268
1974; 53
1987; 93
1997; 112
1992; 327
1992; 38
1991; 337
1992; 33
2001; 429
1993; 104
1998; 42
2009; 136
1970; 58
2007; 15
2004; 51
1984; 2
2005; 128
2008; 43
2005; 3
1999; 276
e_1_2_7_5_2
e_1_2_7_4_2
e_1_2_7_3_2
e_1_2_7_2_2
e_1_2_7_9_2
e_1_2_7_8_2
e_1_2_7_7_2
e_1_2_7_6_2
e_1_2_7_18_2
e_1_2_7_17_2
e_1_2_7_16_2
e_1_2_7_15_2
e_1_2_7_14_2
e_1_2_7_13_2
e_1_2_7_12_2
e_1_2_7_10_2
Koga H (e_1_2_7_24_2) 1999; 276
Fujimori S (e_1_2_7_11_2) 2009; 136
e_1_2_7_26_2
Hao WL (e_1_2_7_19_2) 2004; 268
e_1_2_7_27_2
e_1_2_7_28_2
e_1_2_7_25_2
e_1_2_7_23_2
e_1_2_7_22_2
e_1_2_7_21_2
e_1_2_7_20_2
References_xml – reference: Bjarnason I, Hayllar J, MacPherson AJ, Russel AS. Side effects of non-steroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993;104:1832-47.
– reference: Higuchi K, Yoda Y, Amagase K, Kato S, Tokioka S, Murano M et al. Prevention of NSAID-induced small intestinal mucosal injury: prophylactic potential of lansoprazole. J Clin Biochem Nutr 2009;45:125-30.
– reference: Fujimori S, Seo T, Gudis K, Tanaka S, Mitsui K, Kobayashi T et al. Diagnosis and treatment of obscure gastrointestinal bleeding using combined capsule endoscopy and double balloon endoscopy: 1-year follow-up study. Endoscopy 2007;39:1053-8.
– reference: Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule endoscopy. Gastroenterology 2005;128:1172-8.
– reference: Krag E, Phillips SF. Active and passive bile acid absorption in man. Perfusion studies of the ileum and jejunum. J Clin Invest 1974;53:1686-94.
– reference: Matsumoto T, Kudo T, Esaki M, Yano T, Yamamoto H, Sakamoto C et al. Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gastroenterol 2008;43:490-6.
– reference: Fujimori S, Seo T, Gudis K, Ehara A, Kobayashi T, Mitsui K et al. Prevention of NSAID-induced small intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointest Endosc 2009;69:1339-46.
– reference: Morris AJ, MacKenzie JF. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 1992;33:887-9.
– reference: Fujimori S, Seo T, Takahashi Y, Gudis K, Yamada Y, Tatsuguchi A et al. Prevention of NSAID-induced small intestinal injury by rebamipide: a prospective, double-blind, randomized controlled trial. Gastroenterology 2009;136(Suppl. 1):A880.
– reference: Hao WL, Lee YK. Microflora of the gastrointestinal tract: a review. Methods Mol Biol 2004;268:491-502.
– reference: Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005;3:133-41.
– reference: Morris AJ, Madhok R, Sturrock RD, Capell HA, MacKenzie JF. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet 1991;337:520.
– reference: Reuter BK, Davies NM, Wallace JL. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria and enteropathic circulation. Gastroenterology 1997;112:109-17.
– reference: Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005;3:55-9.
– reference: Kelly DA, Piasecki C, Anthony A, Dhillon AP, Pounder RE, Wakefield AJ. Focal reduction of villous blood flow in early indomethacin enteropathy: a dynamic vascular study in the rat. Gut 1998;42:366-73.
– reference: Whittle BJ. Mechanisms underlying intestinal injury induced by anti-inflammatory COX inhibitors. Eur J Pharmacol 2004;500:427-39.
– reference: Wax J, Clinger WA, Varner P, Bass P, Winder CV. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. Gastroenterology 1970;58:772-80.
– reference: Bjarnason I, Williams P, So A, Zanelli GD, Levi AJ, Gumpel JM et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 1984;2:1171-4.
– reference: Koga H, Aoyagi K, Matsumoto T, Iida M, Fujishima M. Experimental enteropathy in athymic and euthymic rats: synergistic role of lipopolysaccharide and indomethacin. Am J Physiol 1999;276(3 Pt 1):G576-82.
– reference: Hagiwara M, Kataoka K, Arimochi H, Kuwahara T, Ohnishi Y. Role of unbalanced growth of gram-negative bacteria in ileal ulcer formation in rats treated with a nonsteroidal anti-inflammatory drug. J Med Invest 2004;51:43-51.
– reference: Allison MC, Howatson AG, Torrance CJ, Lee FD, Russel RI. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med 1992;327:749-54.
– reference: Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P et al. Non-steroidal anti-inflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987;93:480-9.
– reference: Spittell D, Vongroven LK, Subbiah MT. Concentration changes of bile acids in sequential segments of pigeon intestine and their relation to bile acid absorption. Biochim Biophys Acta 1976;441:32-7.
– reference: Evans SM, Whittle BJ. Interactive roles of superoxide and inducible nitric oxide synthase in rat intestinal injury provoked by non-steroidal anti-inflammatory drugs. Eur J Pharmacol 2001;429:287-96.
– reference: Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Aisenberg J, Bhadra P et al. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther 2007;15:1211-22.
– reference: Bjarnason I, Hayllar J, Smethurst P, Price A, Gumpel MJ. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut 1992;33:1204-8.
– reference: Davies GR, Wilkie ME, Rampton DS. Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability. Dig Dis Sci 1992;38:417-25.
– volume: 93
  start-page: 480
  year: 1987
  end-page: 9
  article-title: Non‐steroidal anti‐inflammatory drug‐induced intestinal inflammation in humans
  publication-title: Gastroenterology
– volume: 33
  start-page: 1204
  year: 1992
  end-page: 8
  article-title: Metronidazole reduces intestinal inflammation and blood loss in non‐steroidal anti‐inflammatory drug induced enteropathy
  publication-title: Gut
– volume: 51
  start-page: 43
  year: 2004
  end-page: 51
  article-title: Role of unbalanced growth of gram‐negative bacteria in ileal ulcer formation in rats treated with a nonsteroidal anti‐inflammatory drug
  publication-title: J Med Invest
– volume: 53
  start-page: 1686
  year: 1974
  end-page: 94
  article-title: Active and passive bile acid absorption in man. Perfusion studies of the ileum and jejunum
  publication-title: J Clin Invest
– volume: 327
  start-page: 749
  year: 1992
  end-page: 54
  article-title: Gastrointestinal damage associated with the use of nonsteroidal anti‐inflammatory drugs
  publication-title: N Engl J Med
– volume: 58
  start-page: 772
  year: 1970
  end-page: 80
  article-title: Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid
  publication-title: Gastroenterology
– volume: 268
  start-page: 491
  year: 2004
  end-page: 502
  article-title: Microflora of the gastrointestinal tract: a review
  publication-title: Methods Mol Biol
– volume: 128
  start-page: 1172
  year: 2005
  end-page: 8
  article-title: A quantitative analysis of NSAID‐induced small bowel pathology by capsule endoscopy
  publication-title: Gastroenterology
– volume: 33
  start-page: 887
  year: 1992
  end-page: 9
  article-title: Small bowel enteroscopy in undiagnosed gastrointestinal blood loss
  publication-title: Gut
– volume: 3
  start-page: 133
  year: 2005
  end-page: 41
  article-title: Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo
  publication-title: Clin Gastroenterol Hepatol
– volume: 500
  start-page: 427
  year: 2004
  end-page: 39
  article-title: Mechanisms underlying intestinal injury induced by anti‐inflammatory COX inhibitors
  publication-title: Eur J Pharmacol
– volume: 104
  start-page: 1832
  year: 1993
  end-page: 47
  article-title: Side effects of non‐steroidal anti‐inflammatory drugs on the small and large intestine in humans
  publication-title: Gastroenterology
– volume: 112
  start-page: 109
  year: 1997
  end-page: 17
  article-title: Nonsteroidal anti‐inflammatory drug enteropathy in rats: role of permeability, bacteria and enteropathic circulation
  publication-title: Gastroenterology
– volume: 15
  start-page: 1211
  year: 2007
  end-page: 22
  article-title: Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy
  publication-title: Aliment Pharmacol Ther
– volume: 3
  start-page: 55
  year: 2005
  end-page: 9
  article-title: Visible small‐intestinal mucosal injury in chronic NSAID users
  publication-title: Clin Gastroenterol Hepatol
– volume: 441
  start-page: 32
  year: 1976
  end-page: 7
  article-title: Concentration changes of bile acids in sequential segments of pigeon intestine and their relation to bile acid absorption
  publication-title: Biochim Biophys Acta
– volume: 39
  start-page: 1053
  year: 2007
  end-page: 8
  article-title: Diagnosis and treatment of obscure gastrointestinal bleeding using combined capsule endoscopy and double balloon endoscopy: 1‐year follow‐up study
  publication-title: Endoscopy
– volume: 45
  start-page: 125
  year: 2009
  end-page: 30
  article-title: Prevention of NSAID‐induced small intestinal mucosal injury: prophylactic potential of lansoprazole
  publication-title: J Clin Biochem Nutr
– volume: 38
  start-page: 417
  year: 1992
  end-page: 25
  article-title: Effects of metronidazole and misoprostol on indomethacin‐induced changes in intestinal permeability
  publication-title: Dig Dis Sci
– volume: 136
  start-page: A880
  issue: Suppl. 1
  year: 2009
  article-title: Prevention of NSAID‐induced small intestinal injury by rebamipide: a prospective, double‐blind, randomized controlled trial
  publication-title: Gastroenterology
– volume: 69
  start-page: 1339
  year: 2009
  end-page: 46
  article-title: Prevention of NSAID‐induced small intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy
  publication-title: Gastrointest Endosc
– volume: 2
  start-page: 1171
  year: 1984
  end-page: 4
  article-title: Intestinal permeability and inflammation in rheumatoid arthritis: effects of non‐steroidal anti‐inflammatory drugs
  publication-title: Lancet
– volume: 429
  start-page: 287
  year: 2001
  end-page: 96
  article-title: Interactive roles of superoxide and inducible nitric oxide synthase in rat intestinal injury provoked by non‐steroidal anti‐inflammatory drugs
  publication-title: Eur J Pharmacol
– volume: 337
  start-page: 520
  year: 1991
  article-title: Enteroscopic diagnosis of small bowel ulceration in patients receiving non‐steroidal anti‐inflammatory drugs
  publication-title: Lancet
– volume: 276
  start-page: G576
  issue: 3 Pt 1
  year: 1999
  end-page: 82
  article-title: Experimental enteropathy in athymic and euthymic rats: synergistic role of lipopolysaccharide and indomethacin
  publication-title: Am J Physiol
– volume: 42
  start-page: 366
  year: 1998
  end-page: 73
  article-title: Focal reduction of villous blood flow in early indomethacin enteropathy: a dynamic vascular study in the rat
  publication-title: Gut
– volume: 43
  start-page: 490
  year: 2008
  end-page: 6
  article-title: Prevalence of non‐steroidal anti‐inflammatory drug‐induced enteropathy determined by double‐balloon endoscopy: a Japanese multicenter study
  publication-title: Scand J Gastroenterol
– ident: e_1_2_7_3_2
  doi: 10.1016/0016-5085(93)90667-2
– ident: e_1_2_7_17_2
  doi: 10.1172/JCI107720
– volume: 136
  start-page: A880
  issue: 1
  year: 2009
  ident: e_1_2_7_11_2
  article-title: Prevention of NSAID‐induced small intestinal injury by rebamipide: a prospective, double‐blind, randomized controlled trial
  publication-title: Gastroenterology
– ident: e_1_2_7_21_2
  doi: 10.1016/S1542-3565(04)00603-2
– ident: e_1_2_7_26_2
  doi: 10.1016/S0014-2999(01)01327-9
– ident: e_1_2_7_22_2
  doi: 10.3164/jcbn.SR09-58
– ident: e_1_2_7_2_2
  doi: 10.1056/NEJM199209103271101
– ident: e_1_2_7_16_2
  doi: 10.1016/0016-5085(87)90909-7
– ident: e_1_2_7_9_2
  doi: 10.1053/j.gastro.2005.03.020
– ident: e_1_2_7_27_2
  doi: 10.1136/gut.33.9.1204
– volume: 268
  start-page: 491
  year: 2004
  ident: e_1_2_7_19_2
  article-title: Microflora of the gastrointestinal tract: a review
  publication-title: Methods Mol Biol
– ident: e_1_2_7_7_2
  doi: 10.1080/00365520701794121
– ident: e_1_2_7_13_2
  doi: 10.1016/S0016-5085(70)80149-4
– ident: e_1_2_7_8_2
  doi: 10.1016/S1542-3565(04)00619-6
– ident: e_1_2_7_25_2
  doi: 10.2152/jmi.51.43
– ident: e_1_2_7_4_2
  doi: 10.1136/gut.33.7.887
– volume: 276
  start-page: G576
  issue: 3
  year: 1999
  ident: e_1_2_7_24_2
  article-title: Experimental enteropathy in athymic and euthymic rats: synergistic role of lipopolysaccharide and indomethacin
  publication-title: Am J Physiol
– ident: e_1_2_7_6_2
  doi: 10.1055/s-2007-967014
– ident: e_1_2_7_23_2
  doi: 10.1136/gut.42.3.366
– ident: e_1_2_7_15_2
  doi: 10.1016/S0140-6736(84)92739-9
– ident: e_1_2_7_5_2
  doi: 10.1016/0140-6736(91)91300-J
– ident: e_1_2_7_28_2
  doi: 10.1007/BF01316493
– ident: e_1_2_7_18_2
  doi: 10.1016/0005-2760(76)90278-2
– ident: e_1_2_7_14_2
  doi: 10.1016/S0016-5085(97)70225-7
– ident: e_1_2_7_20_2
  doi: 10.1111/j.1365-2036.2007.03312.x
– ident: e_1_2_7_12_2
  doi: 10.1016/j.ejphar.2004.07.042
– ident: e_1_2_7_10_2
  doi: 10.1016/j.gie.2008.08.017
SSID ssj0008132
Score 2.2331407
Snippet Eur J Clin Invest 2010; 40 (6): 504–510 Background  Nonsteroidal anti‐inflammatory drugs (NSAIDs) induce small intestinal mucosal injuries. The concentrations...
Nonsteroidal anti-inflammatory drugs (NSAIDs) induce small intestinal mucosal injuries. The concentrations of NSAIDs, bile acids and intestinal flora may...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 504
SubjectTerms Adult
Anti-Inflammatory Agents, Non-Steroidal - adverse effects
Biological and medical sciences
Capsule Endoscopy
denuded area
Diclofenac - adverse effects
Digestive system. Abdomen
distribution
Endoscopy
General aspects
Humans
Intestinal Diseases - chemically induced
Intestinal Diseases - pathology
Intestinal Mucosa - drug effects
Intestinal Mucosa - pathology
Intestine, Small - drug effects
Intestine, Small - injuries
Investigative techniques, diagnostic techniques (general aspects)
Male
Medical sciences
Middle Aged
NSAID
Omeprazole - therapeutic use
Prospective Studies
Proton Pump Inhibitors - therapeutic use
small intestinal injury
Ulcer - chemically induced
Ulcer - pathology
Title Distribution of small intestinal mucosal injuries as a result of NSAID administration
URI https://api.istex.fr/ark:/67375/WNG-HM5GVG0B-X/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2362.2010.02290.x
https://www.ncbi.nlm.nih.gov/pubmed/20412292
https://www.proquest.com/docview/733310282
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELYQSIiF96M8Kg-ILVXS2HmMvNqC1A5AoZt1duyBlhY1rYT49fiStCWoA0JIGaI4FyWXO_vO_vwdIeexnwBozhxXucph9i4HkPc2UbhmloTGU7gbud0JWl123-O9Av-Ee2Fyfoj5hBt6RtZfo4ODTMtOniG0bA9cILSQuryG8SQ2YHz0sGCSijw_Jw73mFOPwx-gnqUPKo1Ua6j0D0ROQmqVZ_KqF8vC0nKUmw1TjS3Sn31gjk7p16YTWVOfP7gf_0cD22SziGbpZW5-O2RFD3fJertYr98j3Rvk5S1KatGRoekbDAYUOSps14Kib4iYB7z0isXzUgr2oGOdTgcTFOg8Xt7dUChR_O6TbuP26brlFIUcHMW5TU8l2J5Cxon2o8AkTDEPk_LIaA0sQQazJIpB191QS87B-IGJAxnxBALtGrCp8gFZHY6G-ohQFnAF2lMmsHkeA1d6XpZD8ljaUUfVKySc_TShCpZzLLYxEN-yHas1gVoTqDWRaU18VIg3l3zPmT5-IXOR2cVcAMZ9RMqFXLx0mqLV5s3npnslehVSLRnOXAB3Ikc2kKgQOrMkYR0cV21gqEfTVIS-72MUaD_tMLewhTCSpdVj2xJkdvLr9xa313d4dvxXwROykcMocDrqlKxOxlN9ZqOziaxmfvcF7pcoag
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9tAEB0hkGgvLdAW0lK6B9SbIzv2-uNICSRpSQ5A2txW4_XuAUxSxYmE-us7YzuhRhwQquSDZXss73hmd2b37RuA48TPEI0MHFe72gnoKQeZ9zbTvGaWRdbTvBt5OAr74-D7RE7qckC8F6bih1hPuLFnlP01OzhPSDe9vIRoURdcQ7SYu7xNAeUWF_hmL-1ePnBJxZ5fUYd7gdNJokewniff1Birtljt94ydxILUZ6u6F08Fps04txyozt9CvmpihU-5bS8XaVv_ecT--J90sANv6oBWnFQWuAsbZroH28N6yf4djLtMzVtX1RIzK4o7zHPBNBXUu7DoHYPmkS_dcP28QiAdYm6KZb5ggdHVyaArsMHy-x7G52fXp32nruXgaCkpQ02ROos0yYwfhzYLdOBxXh5bYzDImMQsixM0HTcyqZRo_dAmYRrLDEPjWqRs-QNsTmdTcwCCfq5G42kbUqoXoJt6XplGyiSlgUd3WhCt_prSNdE519vI1T8JD2lNsdYUa02VWlP3LfDWkr8rso9nyHwtDWMtgPNbBstFUv0a9VR_KHs_e-43NWnBUcNy1gK8GTmmWKIFYmVKinycF25wambLQkW-73MgSE3br0zsQZj50joJ3QlLQ3n2d6uz0wGffXyp4Bd41b8eXqiLwejHJ3hdoSp4duoQNhfzpflMwdoiPSqd8C91ByyD
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hVqq4AOXVQFv2gLg5suPdtX0sTfMAEiEgkNtqvI8DSZMqTqSKX8-M7aR11UOFkHywbI_lHc_szux--w1j77PYAjgpgtCEJhD4VADEe2sNrZnZxEeGdiOPxmowEZ-mclrjn2gvTMUPsZtwI88o-2ty8Cvrm05eIrSwB64RWkRd3sZ4cl-oMKVErPvthkoqjeKKOTwSQSdL7qB67n1TY6jaJ61fE3QSCtSer8pe3BeXNsPccpzqPWWzbQsreMqsvVnnbfPnDvnj_1HBM_akDmf5WWV_h-yRWzxnB6N6wf4Fm3SJmLeuqcWXnheXMJ9zIqnAvoVELwkyD3TpN1XPKzjgwVeu2MzXJDD-fjbscmhw_L5kk97Fj_NBUFdyCIyUmJ_mgF1FnlkXp8pbYUREWXnqnQNhicLMphm4Tpi4XErwsfKZylNpQbnQA-bKr9jeYrlwR4wLJQ24yHiFiZ6AMI-iMomUWY7Djum0WLL9adrUNOdUbWOub6U7qDVNWtOkNV1qTV-3WLSTvKqoPh4g86G0i50ArGYElUuk_jXu68FI9n_2w4962mKnDcPZCdBW5BQjiRbjW0vS6OG0bAMLt9wUOonjmMJAbNrrysJuhIktrZPhHVXayYO_W1-cD-nszb8KvmMHX7s9_WU4_vyWPa4gFTQ1dcz21quNO8FIbZ2fli74F9PyKzs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Distribution+of+small+intestinal+mucosal+injuries+as+a+result+of+NSAID+administration&rft.jtitle=European+journal+of+clinical+investigation&rft.au=FUJIMORI%2C+Shunji&rft.au=GUDIS%2C+Katya&rft.au=TATSUGUCHI%2C+Atsushi&rft.au=SAKAMOTO%2C+Choitsu&rft.date=2010-06-01&rft.pub=Wiley-Blackwell&rft.issn=0014-2972&rft.volume=40&rft.issue=6&rft.spage=504&rft.epage=510&rft_id=info:doi/10.1111%2Fj.1365-2362.2010.02290.x&rft.externalDBID=n%2Fa&rft.externalDocID=22788413
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-2972&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-2972&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-2972&client=summon